DEEPEXI TECH (01384) Soars Over 50% Following Bullish Initiation by GTHT with HK$61.10 Target

Stock News04-10

DEEPEXI TECH (01384) saw its gains expand to over 50%. At the time of writing, the stock was up 51.77%, trading at HK$45.5, with a turnover of HK$1.101 billion.

The surge follows the company's recent disclosure of its annual results, which showed a 70.8% year-on-year surge in total revenue, while its adjusted net loss narrowed significantly by 71.4%. Notably, revenue from its FastAGI enterprise-grade AI solution skyrocketed to RMB 254 million, a surge of 181.5% year-on-year, making it the largest revenue contributor. This growth was primarily driven by the expansion of the group's customer base, which increased from 20 customers as of 2024 to 70 customers by 2025.

GTHT Securities initiated coverage on DEEPEXI TECH with an "Add" rating. The brokerage noted that the company is benefiting from "cost-effective open-source foundational models coupled with strong demand for intelligent solutions across various industry verticals," propelling its revenue onto a fast track. GTHT forecasts the company's revenue for 2026-2028 to reach RMB 870 million, RMB 1.685 billion, and RMB 2.887 billion, respectively. Using a PS valuation method, the firm assigned a 2026 price-to-sales multiple of 20x, resulting in a valuation of RMB 1.7404 billion. This corresponds to a target price of HK$61.10 (based on an exchange rate of RMB 1 to HK$1.1468).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment